VRXI OABI veraxa Biotech announces advancement of novel bispecific antibody drug conjugate program vxa-222 from Joint Discovery collaboratio

VRXI OABI veraxa Biotech announces advancement of novel bispecific antibody drug conjugate program vxa-222 from Joint Discovery collaboration with Omniab